C
CSPC Pharmaceutical Group Ltd
HKEX:1093
CSPC Pharmaceutical Group Ltd
HKEX:1093
Price:
4.94
HKD
-2.37%
Market Closed
Market Cap:
57B
HKD
Balance Sheet
Balance Sheet Decomposition
CSPC Pharmaceutical Group Ltd
CSPC Pharmaceutical Group Ltd
| Current Assets | 26.5B |
| Cash & Short-Term Investments | 11.7B |
| Receivables | 11.6B |
| Other Current Assets | 3.2B |
| Non-Current Assets | 21.4B |
| Long-Term Investments | 6.5B |
| PP&E | 11.6B |
| Intangibles | 2.5B |
| Other Non-Current Assets | 815.6m |
Balance Sheet
CSPC Pharmaceutical Group Ltd
CSPC Pharmaceutical Group Ltd
Currency: CNY
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1 320
|
1 918
|
2 897
|
4 691
|
4 336
|
4 118
|
7 259
|
9 284
|
8 001
|
12 015
|
|
| Cash |
1 320
|
1 918
|
2 897
|
4 691
|
4 336
|
4 118
|
7 259
|
9 284
|
8 001
|
12 015
|
|
| Short-Term Investments |
1
|
1
|
0
|
1 179
|
2 293
|
1 839
|
1 535
|
1 643
|
5 795
|
2 577
|
|
| Total Receivables |
2 726
|
2 725
|
2 720
|
3 497
|
3 629
|
4 451
|
4 745
|
6 549
|
6 836
|
9 841
|
|
| Accounts Receivables |
1 606
|
1 426
|
1 394
|
1 719
|
2 128
|
2 399
|
2 543
|
3 409
|
4 105
|
6 026
|
|
| Other Receivables |
1 120
|
1 299
|
1 327
|
1 777
|
1 501
|
2 052
|
2 202
|
3 139
|
2 732
|
3 815
|
|
| Inventory |
1 623
|
1 517
|
1 731
|
2 598
|
3 045
|
2 536
|
1 861
|
2 480
|
2 555
|
3 139
|
|
| Other Current Assets |
216
|
217
|
198
|
246
|
501
|
754
|
521
|
604
|
770
|
697
|
|
| Total Current Assets |
5 936
|
6 379
|
7 548
|
12 211
|
13 803
|
13 697
|
15 921
|
20 337
|
23 957
|
26 745
|
|
| PP&E Net |
4 537
|
4 289
|
4 850
|
5 967
|
6 692
|
9 282
|
8 934
|
9 564
|
10 977
|
11 643
|
|
| PP&E Gross |
4 537
|
4 289
|
4 850
|
5 967
|
6 692
|
9 282
|
8 934
|
9 564
|
10 977
|
11 643
|
|
| Accumulated Depreciation |
766
|
1 529
|
1 882
|
2 467
|
2 804
|
3 290
|
3 243
|
3 863
|
4 619
|
5 412
|
|
| Intangible Assets |
100
|
80
|
71
|
92
|
807
|
1 136
|
509
|
468
|
1 908
|
2 199
|
|
| Goodwill |
112
|
100
|
100
|
109
|
141
|
189
|
150
|
150
|
235
|
235
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
150
|
757
|
254
|
0
|
0
|
|
| Long-Term Investments |
69
|
23
|
154
|
382
|
899
|
1 486
|
3 176
|
3 356
|
3 783
|
4 655
|
|
| Other Long-Term Assets |
479
|
422
|
497
|
532
|
875
|
378
|
623
|
613
|
910
|
806
|
|
| Other Assets |
112
|
100
|
100
|
109
|
141
|
189
|
150
|
150
|
235
|
235
|
|
| Total Assets |
11 234
N/A
|
11 293
+1%
|
13 219
+17%
|
19 293
+46%
|
23 217
+20%
|
26 318
+13%
|
30 070
+14%
|
34 742
+16%
|
41 770
+20%
|
46 282
+11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
883
|
957
|
998
|
1 339
|
1 619
|
1 111
|
1 205
|
1 481
|
1 703
|
2 473
|
|
| Accrued Liabilities |
118
|
93
|
176
|
312
|
446
|
371
|
386
|
519
|
728
|
842
|
|
| Short-Term Debt |
204
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
561
|
377
|
804
|
830
|
71
|
97
|
224
|
38
|
296
|
600
|
|
| Other Current Liabilities |
1 471
|
1 478
|
1 681
|
2 678
|
5 111
|
4 657
|
4 488
|
5 187
|
6 231
|
6 268
|
|
| Total Current Liabilities |
3 237
|
2 906
|
3 658
|
5 158
|
7 247
|
6 237
|
6 302
|
7 226
|
8 958
|
10 183
|
|
| Long-Term Debt |
541
|
843
|
215
|
54
|
0
|
90
|
93
|
56
|
287
|
107
|
|
| Deferred Income Tax |
27
|
39
|
62
|
118
|
238
|
304
|
320
|
381
|
612
|
575
|
|
| Minority Interest |
65
|
62
|
75
|
76
|
477
|
1 056
|
769
|
842
|
1 444
|
1 815
|
|
| Other Liabilities |
104
|
155
|
157
|
165
|
202
|
169
|
254
|
250
|
271
|
400
|
|
| Total Liabilities |
3 974
N/A
|
4 005
+1%
|
4 167
+4%
|
5 571
+34%
|
8 165
+47%
|
7 857
-4%
|
7 738
-2%
|
8 755
+13%
|
11 572
+32%
|
13 079
+13%
|
|
| Equity | |||||||||||
| Common Stock |
8 825
|
8 203
|
9 466
|
11 573
|
10 899
|
10 899
|
10 899
|
10 899
|
10 899
|
10 899
|
|
| Retained Earnings |
1 637
|
632
|
467
|
2 295
|
4 055
|
7 399
|
11 523
|
15 155
|
19 163
|
22 225
|
|
| Additional Paid In Capital |
41
|
38
|
51
|
51
|
47
|
47
|
47
|
47
|
197
|
391
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
3
|
53
|
237
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
101
|
101
|
86
|
84
|
316
|
|
| Other Equity |
32
|
321
|
933
|
200
|
2
|
20
|
36
|
28
|
22
|
5
|
|
| Total Equity |
7 260
N/A
|
7 288
+0%
|
9 052
+24%
|
13 723
+52%
|
15 052
+10%
|
18 462
+23%
|
22 332
+21%
|
25 987
+16%
|
30 198
+16%
|
33 203
+10%
|
|
| Total Liabilities & Equity |
11 234
N/A
|
11 293
+1%
|
13 219
+17%
|
19 293
+46%
|
23 217
+20%
|
26 318
+13%
|
30 070
+14%
|
34 742
+16%
|
41 770
+20%
|
46 282
+11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5 908
|
11 349
|
11 621
|
11 987
|
11 974
|
11 974
|
11 974
|
11 950
|
11 933
|
11 903
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
